Author

Paula Haddock

Observed names: Haddock, Paula, P Haddock

Institution: Queen's University Belfast

Observed institutions: Queen's University Belfast, Mayo Clinic, Almac (United Kingdom)

OpenAlex ID: A5079603792

Live-Attenuated Measles Virus Vaccine Targets Dendritic Cells and Macrophages in Muscle of Nonhuman Primates

2014 · Linda J. Rennick, Rory D. de Vries, et al. · Journal of Virology · 55

Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs)

2016 · Katy Orr, Niamh E. Buckley, et al. · Oncotarget · 40

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer

2016 · Niamh E. Buckley, Paula Haddock, et al. · Oncotarget · 37

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

2019 · Paul B. Mullan, Victoria Bingham, et al. · BMC Cancer · 17

Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

2020 · Ahmed Elkashif, Victoria Bingham, et al. · Journal of Oncology · 14

Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer

2020 · Catherine Knowlson, Paula Haddock, et al. · Therapeutic Advances in Medical Oncology · 7

A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancers

2024 · Charlotte Zoe Angel, Shannon Beattie, et al. · Cell Communication and Signaling · 3

Monitoring and Evaluating

2015 · Paula Haddock · 2

The multifaceted role of the potassium channel KCNK1 in the early detection and prognostication of high-grade serous cancer

2026 · Subarnarekha Chatterji, Elaine Craig, et al. · Journal of Ovarian Research

Developing a Personalised Medicine Approach for Triple Negative Breast Cancer: The Role of the Glucocorticoid Receptor in response to Chemotherapy

2018 · Ahmed Elkashif, Paula Haddock, et al. · Research Portal (Queen's University Belfast)

Abstract 2270: A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer

2016 · Niamh E. Buckley, Paula Haddock, et al. · Cancer Research

PD10-05: Identification of Novel BRCA1 Transcriptional Targets That Promote the Survival of BRCA1-Mutated Estrogen Receptor-a Negative (ER-ve) Breast Tumours.

2011 · E Lamers, P Haddock, et al. · Cancer Research

Works count: 29

Citation count: 175

H-index: 6

I10-index: 5